Nothing Special   »   [go: up one dir, main page]

SE9303627D0 - Method and means for prevention of cataract - Google Patents

Method and means for prevention of cataract

Info

Publication number
SE9303627D0
SE9303627D0 SE9303627A SE9303627A SE9303627D0 SE 9303627 D0 SE9303627 D0 SE 9303627D0 SE 9303627 A SE9303627 A SE 9303627A SE 9303627 A SE9303627 A SE 9303627A SE 9303627 D0 SE9303627 D0 SE 9303627D0
Authority
SE
Sweden
Prior art keywords
pct
prevention
date
sec
prostaglandins
Prior art date
Application number
SE9303627A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9303627A priority Critical patent/SE9303627D0/sv
Publication of SE9303627D0 publication Critical patent/SE9303627D0/sv
Priority to AU81197/94A priority patent/AU695162B2/en
Priority to JP7513172A priority patent/JPH09504543A/ja
Priority to EP95900348A priority patent/EP0726769A1/en
Priority to US08/632,486 priority patent/US5773472A/en
Priority to CA002175595A priority patent/CA2175595A1/en
Priority to PCT/SE1994/001035 priority patent/WO1995012401A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Window Of Vehicle (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9303627A 1993-11-03 1993-11-03 Method and means for prevention of cataract SE9303627D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9303627A SE9303627D0 (sv) 1993-11-03 1993-11-03 Method and means for prevention of cataract
AU81197/94A AU695162B2 (en) 1993-11-03 1994-11-03 Method and means for prevention of cataract
JP7513172A JPH09504543A (ja) 1993-11-03 1994-11-03 白内障の予防法及び予防手段
EP95900348A EP0726769A1 (en) 1993-11-03 1994-11-03 Method and means for prevention of cataract
US08/632,486 US5773472A (en) 1993-11-03 1994-11-03 Method and means for prevention of cataract
CA002175595A CA2175595A1 (en) 1993-11-03 1994-11-03 Method and means for prevention of cataract
PCT/SE1994/001035 WO1995012401A1 (en) 1993-11-03 1994-11-03 Method and means for prevention of cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303627A SE9303627D0 (sv) 1993-11-03 1993-11-03 Method and means for prevention of cataract

Publications (1)

Publication Number Publication Date
SE9303627D0 true SE9303627D0 (sv) 1993-11-03

Family

ID=20391628

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303627A SE9303627D0 (sv) 1993-11-03 1993-11-03 Method and means for prevention of cataract

Country Status (7)

Country Link
US (1) US5773472A (sv)
EP (1) EP0726769A1 (sv)
JP (1) JPH09504543A (sv)
AU (1) AU695162B2 (sv)
CA (1) CA2175595A1 (sv)
SE (1) SE9303627D0 (sv)
WO (1) WO1995012401A1 (sv)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655002B2 (en) 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US6379664B1 (en) 1998-09-29 2002-04-30 Board Of Regents University Of Nebraska-Lincoln Composition and method for the prevention and treatment of oxidative damage in ocular tissues
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6533769B2 (en) * 2001-05-03 2003-03-18 Holmen Joergen Method for use in cataract surgery
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
PT1499361E (pt) * 2002-04-19 2012-11-22 Novartis Ag Novos biomateriais, sua preparação e utilização
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US8262646B2 (en) 2006-01-20 2012-09-11 Lensar, Inc. System and method for providing the shaped structural weakening of the human lens with a laser
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
CA2769090A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for providing laser shot patterns to the lens of an eye
WO2011011788A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for performing ladar assisted procedures on the lens of an eye
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
KR101769637B1 (ko) * 2009-11-09 2017-08-18 알러간, 인코포레이티드 모발 성장을 촉진하기 위한 조성물 및 방법
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
EP2531089B1 (en) 2010-02-01 2023-04-05 LENSAR, Inc. Purkinjie image-based alignment of suction ring in ophthalmic applications
IT1398378B1 (it) * 2010-02-22 2013-02-22 Omikron Italia S R L Citicolina per il trattamento del glaucoma e dell'ipertensione oculare.
EP4205633A1 (en) 2010-10-15 2023-07-05 Lensar, Inc. System and method of scan controlled illumination of structures within an eye
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
US9393154B2 (en) 2011-10-28 2016-07-19 Raymond I Myers Laser methods for creating an antioxidant sink in the crystalline lens for the maintenance of eye health and physiology and slowing presbyopia development
CN112040943A (zh) 2018-05-01 2020-12-04 曹季南 可治愈白内障老花眼等的滴眼剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306731A (en) * 1985-06-14 1994-04-26 Massachusetts Eye And Ear Infirmary Method and products for treating the eye
TW249226B (sv) * 1990-04-04 1995-06-11 Aderk Ueno Kk
TW205508B (sv) * 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo

Also Published As

Publication number Publication date
AU8119794A (en) 1995-05-23
CA2175595A1 (en) 1995-05-11
US5773472A (en) 1998-06-30
WO1995012401A1 (en) 1995-05-11
JPH09504543A (ja) 1997-05-06
EP0726769A1 (en) 1996-08-21
AU695162B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
SE9303627D0 (sv) Method and means for prevention of cataract
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE161731T1 (de) Anwendung von nor- und homo-gallensäurederivaten als absorptienförderer für arzneimittel
EG20764A (en) Pharmaceutical emulsion
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
NO954952D0 (no) Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
GR3023677T3 (en) Neutral auto-gloss emulsion for the maintenance of floors (iii).
ES2157255T3 (es) Composicion farmaceutica en forma de un estuche de componentes.
BR9408195A (pt) Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina
FI952855A (sv) Nya trizolokinazoliner, framställning och användning av dem
NO964921L (no) Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse